Robert Janssen
2018
In 2018, Robert Janssen earned a total compensation of $1.7M as Chief Medical Officer and Senior Vice President, Clinical Development, Medical and Regulatory Affairs at Dynavax Technologies, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,810 |
|---|---|
| Option Awards | $1,083,000 |
| Salary | $438,000 |
| Other | $2,000 |
| Total | $1,739,810 |
Janssen received $1.1M in option awards, accounting for 62% of the total pay in 2018.
Janssen also received $216.8K in non-equity incentive plan, $438K in salary and $2K in other compensation.
Rankings
In 2018, Robert Janssen's compensation ranked 6,428th out of 14,244 executives tracked by ExecPay. In other words, Janssen earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,428 out of 14,244 | 55th |
Division Manufacturing | 2,458 out of 5,759 | 57th |
Major group Chemicals And Allied Products | 914 out of 2,122 | 57th |
Industry group Drugs | 768 out of 1,811 | 58th |
Industry Pharmaceutical Preparations | 596 out of 1,385 | 57th |
Pay ratio
| Robert Janssen's Pay | $1,739,810 |
|---|---|
| Median Employee's Pay | $162,137 |
| Pay Ratio | 11to 1 |
In 2018, the annual total compensation of Robert Janssen was $1,739,810.
The annual total compensation of the median employee at Dynavax Technologies was $162,137.
The ratio of Robert Janssen's pay to the pay of median employee was therefore 11 to one.
Source: SEC filing on April 22, 2019.
Janssen's colleagues
We found four more compensation records of executives who worked with Robert Janssen at Dynavax Technologies in 2018.